Skip to main content

Advertisement

Log in

Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

The Rome III diagnostic criteria had been used to diagnose functional gastrointestinal disorders (FGIDs) world wide, and functional bowel disorders (FBDs) including irritable bowel syndrome (IBS) have recently attracted the attention of Japanese physicians. However, there have been few reports on the prevalence of FBDs diagnosed by the Rome III diagnostic criteria.

Aims

The aim of this study was to determine the prevalence of FBDs diagnosed according to the diagnostic criteria of Rome III in Japan.

Patients and methods

All patients who were booked for colonoscopy were enrolled from eight institutions in Japan. This study was a prospective observational study in the period from April 2013 to December 2013. Patients filled out FGID questionnaires of Rome III when they were waiting for colonoscopy.

Results

Data for 1200 patients who underwent colonoscopy were analyzed. A total of 547 patients (45.6%) were diagnosed with FBDs. Out of those patients, 9.1% had IBS. According to the Rome III diagnostic criteria, 134 patients (11.2%) had functional bloating (FB), 73 (6.1%) had functional constipation (FC), 40 (3.3%) had functional diarrhea (FD), and 191 (15.9%) had unspecified functional bowel disorder (UFBD). Patients with FBDs had significantly higher rates of almost all symptoms (abdominal pain, hard or lumpy stools, loose or watery stools, and bloating) than those in the controls.

Conclusions

In Japan, the prevalence of FBDs and IBS is high, similar to that in the US. Many patients with FBDs have multiple symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CS:

Colonoscopy

FAPS:

Functional abdominal pain syndrome

FB:

Functional bloating

FBDs:

Functional bowel disorders

FC:

Functional constipation

FD:

Functional diarrhea

FGIDs:

Functional gastrointestinal disorders

IBD:

Inflammatory bowel disease

IBS:

Irritable bowel syndrome

UFBD:

Unspecified functional bowel disorder

References

  1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–90.

    Article  PubMed  Google Scholar 

  2. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480–91.

    Article  PubMed  Google Scholar 

  3. Jellema P, van der Windt DA, Schellevis FG, et al. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther. 2009;30:695–706.

    Article  PubMed  CAS  Google Scholar 

  4. Chang FY, Chen PH, Wu TC, et al. Prevalence of functional gastrointestinal disorders in Taiwan: questionnaire-based survey for adults based on the Rome III criteria. Asia Pac J Clin Nutr. 2012;21:594–600.

    PubMed  Google Scholar 

  5. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(712–721):e714.

    Google Scholar 

  6. Kanazawa M, Endo Y, Whitehead WE, et al. Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci. 2004;49:1046–53.

    Article  PubMed  Google Scholar 

  7. Kubo M, Fujiwara Y, Shiba M, et al. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterol Motil. 2011;23:249–54.

    Article  PubMed  CAS  Google Scholar 

  8. Kumano H, Kaiya H, Yoshiuchi K, et al. Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol. 2004;99:370–6.

    Article  PubMed  Google Scholar 

  9. Miwa H. Life style in persons with functional gastrointestinal disorders—large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil. 2012;24(464–471):e217.

    Google Scholar 

  10. Jung HK, Halder S, McNally M, et al. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population. Aliment Pharmacol Ther. 2007;26:453–61.

    Article  PubMed  Google Scholar 

  11. Sorouri M, Pourhoseingholi MA, Vahedi M, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol. 2010;16:154–60.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Long Y, Huang Z, Deng Y, et al. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil. 2017;29:e12897

    Article  Google Scholar 

  13. Drossman DA, Li Z, Andruzzi E, Temple RD, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–80.

    Article  PubMed  CAS  Google Scholar 

  14. Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient Prefer Adherence. 2008;2:143–7.

    PubMed  PubMed Central  Google Scholar 

  15. Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010;25:1151–6.

    Article  PubMed  Google Scholar 

  16. Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009;30:643–51.

    Article  PubMed  CAS  Google Scholar 

  17. Makharia GK, Verma AK, Amarchand R, et al. Prevalence of irritable bowel syndrome: a community-based study from northern India. J Neurogastroenterol Motil. 2011;17:82–7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Krogsgaard LR, Engsbro AL, Bytzer P. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤ 50 years of age. Scand J Gastroenterol. 2013;48:523–9.

    Article  PubMed  Google Scholar 

  19. Lin S, Mooney PD, Kurien M, et al. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes. Eur J Gastroenterol Hepatol. 2014;26:1176–80.

    Article  PubMed  Google Scholar 

  20. Perveen I, Rahman MM, Saha M, et al. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh. Indian J Gastroenterol. 2014;33:265–73.

    Article  PubMed  Google Scholar 

  21. Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther. 2010;32:738–55.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225–35.

    Article  PubMed  CAS  Google Scholar 

  23. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988;95:701–8.

    Article  PubMed  CAS  Google Scholar 

  24. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population-based study. Gut. 1997;41:394–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Nakajima S, Takahashi K, Sato J, et al. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping. J Gastroenterol Hepatol. 2010;25(Suppl 1):S138–43.

    Article  PubMed  Google Scholar 

  26. Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50:11–30.

    Article  PubMed  CAS  Google Scholar 

  27. Marlicz W, Skonieczna-Zydecka K, Yung DE, et al. Endoscopic findings and colonic perforation in microscopic colitis: a systematic review. Dig Liver Dis. 2017;49:1073–85.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Dr. Uehara and Dr. Hokari for participation this study. Mototsugu Kato has served in speaking and teaching commitments for Eisai Co., Ltd., Daiichi Sankyo Company, Ltd., Takeda Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co., Ltd. and AstraZeneca and has received scholarship grants from Eisai Co., Ltd., Takeda Pharmaceutical Co. Ltd., Daiichi Sankyo Company, Ltd., AstraZeneca and Astellas Pharma Inc. Sakamoto received a research grant from Daiichi-Sankyo, Gilead Sciences, and MSD, and received lecture fees from Bristol-Myers-Squibb, Gilead Sciences, MSD, Otsuka Pharmaceutical, and AbbVie.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayoshi Ono.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ono, M., Kato, M., Miyamoto, S. et al. Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan. J Gastroenterol 53, 916–923 (2018). https://doi.org/10.1007/s00535-017-1428-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-017-1428-9

Keywords

Navigation